Literature DB >> 26892221

Comparative analysis the binding affinity of mycophenolic sodium and meprednisone with human serum albumin: Insight by NMR relaxation data and docking simulation.

Xiaoli Ma1, Jiawei He1, Jin Yan1, Qing Wang1, Hui Li2.   

Abstract

Mycophenolic sodium is an immunosuppressive agent that is always combined administration with corticosteroid in clinical practice. Considering the distribution and side-effect of the drug may change when co-administrated drug exist, this paper comparatively analyzed the binding ability of mycophenolic sodium and meprednisone toward human serum albumin by nuclear magnetic resonance relaxation data and docking simulation. The nuclear magnetic resonance approach was based on the analysis of proton selective and non-selective relaxation rate enhancement of the ligand in the absence and presence of macromolecules. The contribution of the bound ligand fraction to the observed relaxation rate in relation to protein concentration allowed the calculation of the affinity index. This approach allowed the comparison of the binding affinity of mycophenolic sodium and meprednisone. Molecular modeling was operated to simulate the binding model of ligand and albumin through Autodock 4.2.5. Competitive binding of mycophenolic sodium and meprednisone was further conducted through fluorescence spectroscopy.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  Docking simulation; Human serum albumin; Meprednisone; Mycophenolic sodium; Nuclear magnetic resonance

Mesh:

Substances:

Year:  2016        PMID: 26892221     DOI: 10.1016/j.cbi.2016.02.009

Source DB:  PubMed          Journal:  Chem Biol Interact        ISSN: 0009-2797            Impact factor:   5.192


  3 in total

1.  Interaction mechanism of olaparib binding to human serum albumin investigated with NMR relaxation data and computational methods.

Authors:  Yuanming Zhai; Pengchi Deng; Xiaoyan Wang; Chunchun Zhang; Ruixue Gan; Na Gan; Qiaomei Sun; Hui Li
Journal:  RSC Adv       Date:  2018-09-10       Impact factor: 4.036

2.  Weakening Impact of Excessive Human Serum Albumin (eHSA) on Cisplatin and Etoposide Anticancer Effect in C57BL/6 Mice with Tumor and in Human NSCLC A549 Cells.

Authors:  Zhen Yang; Ting Zhou; Yuanchi Cheng; Mingming Li; Xianglin Tan; Feng Xu
Journal:  Front Pharmacol       Date:  2016-11-15       Impact factor: 5.810

3.  Rapid Investigation and Screening of Bioactive Components in Simo Decoction via LC-Q-TOF-MS and UF-HPLC-MD Methods.

Authors:  Yingjie He; Pi Cheng; Wei Wang; Sien Yan; Qi Tang; Dongbo Liu; Hongqi Xie
Journal:  Molecules       Date:  2018-07-20       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.